title: Antithrombotic Therapy After Transcatheter Aortic Valve Implantation.
abstract: Current guidelines for patients who are undergoing transcatheter aortic valve implantation but who do not require anticoagulation recommend double antiplatelet therapy for 3-6 months after the procedure, followed by aspirin indefinitely. However, these guidelines are based on expert consensus rather than clinical trials. Several randomized trials are currently evaluating alternative antithrombotic strategies, and recommendations will likely change when their results become available.
authors.affiliation: University Hospital La Paz, Paseo de la Castellana, 261, 28046, Madrid, Spain. raulmorenog@hotmail.com.
authors.forename: Raul
authors.initials: R
authors.lastname: Moreno
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006349:Heart Valve Diseases / Q000175:diagnosis / Q000188:drug therapy* / Q000601:surgery*; D006801:Humans; D011183:Postoperative Complications / Q000175:diagnosis / Q000517:prevention & control; D012307:Risk Factors; D065467:Transcatheter Aortic Valve Replacement / Q000009:adverse effects / Q000639:trends*
chemical_list: D000925:Anticoagulants; D005343:Fibrinolytic Agents; D001241:Aspirin